Consumer Cyclical
Kits Eyecare Ltd.(KTYCF)
Live Price
Offline$9.09
-2.64% today
1Y Change
-9.96%
Window
Jun 25, 2025 β Jun 18, 2026
- Market Cap
- $490.00M
- Revenue Growth
- +27.0%
- EPS Growth
- -2.0%
- Dividend Yield
- 0.0%
Coverage: 247 bars Β· Jun 25, 2025 β Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Kits Eyecare Ltd. (KTYCF) is a Consumer Cyclical stock with a market cap of $490.00M and listed on OTC. The stock last traded around $9.09 and down 10.0% across the available one-year price window (Jun 25, 2025 β Jun 18, 2026). Baseline metrics include revenue growth of +27.0%, EPS growth of -2.0%, a dividend yield of 0.0%. What stands out right now is revenue +27.0%, EPS -2.0%, free cash flow +14.5% with operating margin 3.2% and ROIC 5.1%. Valuation already assumes a fairly strong business story at P/E 147.9 and price/sales 2.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines KTYCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+27.0% vs +7.5% peer median
Operating Margin
Below sector median
+3.2% vs +8.4% peer median
P/E
Above sector median
147.9 vs 18.1 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +27.0% and EPS is at -2.0%, with operating margin around 3.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -14.3% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | β | -11.8% | -21.0% | -8.7% |
2026 Mar 4, 2026 | -4.6% | -11.3% | -16.4% | -13.1% |
2025 Aug 5, 2025 | -168.5% | -3.6% | -5.5% | -2.5% |
Benchmark Edge
KTYCF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
KTYCF
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
KTYCF Max Drawdown
-51.73%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for KTYCF and SPY.
Company Overview
Kits Eyecare Ltd.
Other OTC
Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada. The company manufactures progressive and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. It operates through a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
- Leadership
- Roger V. Hardy
- IPO Date
- Apr 7, 2021
- Employees
- 162
- Street Address
- 510 Seymour Street
- Mailing
- Vancouver, BC, V6B 3J5
- Region
- Vancouver, BC, CA
- Reporting Currency
- USD
- Investor Line
- +1 833 221 5487
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 147.9
- EV/EBITDA
- 50.1
- Price/Sales
- 2.4
- Price/Book
- 7.4
Growth
- Revenue
- +27.0%
- EPS
- -2.0%
- Free Cash Flow
- +14.5%
Profitability
- Gross Margin
- 35.4%
- Operating Margin
- 3.2%
- Net Margin
- 1.5%
- ROE
- 5.1%
- ROIC
- 5.1%
Balance Sheet
- Debt/Equity
- 0.25
- Current Ratio
- 1.34
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.